
CRISPR gene editing is transforming medicine by targeting the genetic roots of inherited diseases once thought untreatable. While eliminating all hereditary disorders within a generation remains unlikely, scientists are making remarkable progress against conditions like sickle cell disease and β-thalassemia, bringing humanity closer than ever to rewriting its genetic future. Read more

CRISPR 2.0 represents a major leap in gene editing technology, allowing scientists to modify DNA without breaking both strands. Developed through breakthroughs in base editing and prime editing since 2016, this next-generation approach promises safer genetic corrections and new treatments for inherited diseases once considered untreatable. Read more